Android app on Google Play

JPMorgan Downgrades Synageva BioPharma (GEVA) to Neutral

May 10, 2013 6:34 AM EDT Send to a Friend
Get Alerts GEVA Hot Sheet
Price: $68.41 -5.91%

Rating Summary:
    10 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 26 | Down: 32 | New: 6
Trade GEVA Now!
Join SI Premium – FREE
JPMorgan downgraded Synageva BioPharma (NASDAQ: GEVA) from Overweight to Neutral with a price target of $50.00 (from $57.00).

For an analyst ratings summary and ratings history on Synageva BioPharma click here. For more ratings news on Synageva BioPharma click here.

Shares of Synageva BioPharma closed at $45.79 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

JPMorgan

Add Your Comment